FDA recall record

Primidone Tablets, USP, 250 mg, 100 Tablets recall — FDA D-0536-2026

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Class IIIclassification
D-0536-2026official record ID
May 27, 2026report date

Recall record at a glance

Official recordD-0536-2026
CategoryDrug Recalls
ClassificationClass III
FDA record statusOngoing
Recalling firmAmerisource Health Services LLC
Report dateMay 27, 2026
Recall initiation dateMay 1, 2026
Quantity63,500 tablets
LocationColumbus, OH, United States

Official product description

Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC: 68084-203-01; Individual Dose NDC: 68084-203-11

Why the product was recalled

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Distribution information

USA Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.